CistanosideC

CAS No. 120406-34-0

CistanosideC( ——— )

Catalog No. M39128 CAS No. 120406-34-0

Cistanoside C (Jionoside D) is a hydroxycinnamic acid esters of phenethylalcohol glycoside, that can be isolated from roots of Rehmannia glutinosa var. purpurea.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 323 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CistanosideC
  • Note
    Research use only, not for human use.
  • Brief Description
    Cistanoside C (Jionoside D) is a hydroxycinnamic acid esters of phenethylalcohol glycoside, that can be isolated from roots of Rehmannia glutinosa var. purpurea.
  • Description
    Jionoside D exhibits antioxidant property.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    120406-34-0
  • Formula Weight
    638.61
  • Molecular Formula
    C30H38O15
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sasaki H, et al. Hydroxycinnamic acid esters of phenethylalcohol glycosides from Rehmannia glutinosa var. PurpureaJ. Phytochemistry, 1989, 28(3):875-879.
molnova catalog
related products
  • tris(dibenzylideneac...

    tris(dibenzylideneacetone)dipalladium is a N-myristoyltransferase-1 (NMT-1) inhibitor.

  • α-Factor Mating Pher...

    The alpha factor pheromone arrests yeast in the G1 phase of their cell cycle. Alpha Factor Mating Pheromone induces the expression of mating genes, changes in nuclear architecture, and polarzes growth toward the mating partner.

  • Ladiratuzumab

    LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.